09/06/2023 — NIH Sex Differences in Radiation Research: Models, Underlying Pathways, Biomarkers of Injury, and Medical Countermeasure Responses (U01 Clinical Trial Not Allowed)
09/26/2023 — NIH Center without Walls for PET Ligand Development for Alzheimer's disease-related dementias (ADRDs) (U19 - Clinical Trial Optional)
09/30/2023 — NEI Center Core Grant for Vision Research (P30 Clinical Trial Not Allowed)
05/31/2023 — Military Burn Research Program (MBRP) - CTRA, TTDA awards
06/06/2023 — Breast Cancer Research Program (BCRP) - CREA awards
06/08/2023 — Traumatic Brain Injury Research and Psychological Health Research Program – CTA, FPA, HSRA, IIRA, TRA
06/27/2023 — Orthotics and Prosthetics Outcomes Research Program (OPORP) - CRA, CTA awards
06/29/2023 — Breast Cancer Research Program (BCRP) - BTA12-2, EOHS-2, TBCCDA-2, BTA3-2, BTA4-2, INNOV-2
07/27/2023 — Parkinson’s Research Program (PRP) - EIRA, IIRA, SIA
08/03/2023 — Prostate Cancer Research Program (PCRP) - DSA, EIRA, EHDA, HDRA, IDA, PRA, TSA awards
Specialized Alcohol Research Centers (P50 Clinical trial Optional)
Comprehensive Alcohol Research Centers (P60 Clinical trial Optional)
National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN)
Does your innovation need help to move forward? The Startup Toolbox microgrant program is now accepting applications! This program offers direct funding for commercialization services, generously supported by CU Innovations, the Gates Institute, and the Colorado Office of Economic Development & International Trade.
If you are a faculty member, student, or staff at CU Anschutz, CU Denver, or Children's Colorado, you are eligible to apply to support your biomedical invention.
Don't hesitate to take advantage of this opportunity to bring your innovation to market. Apply now!
The Keynote speaker will be C. Edwin Garner, PhD, Principal, Mammoth Preclinical Consulting. The virtual event will be bridging the gap between drug discovery and development requires a focus on optimizing lead molecules for drug like properties.
This talk describes early IND enabling studies and gives examples of successful and not so successful candidates for development with emphasis on pharmacokinetics.
The webinar is May 24, 2023, from 4 to 5pm. Register here for more details.
This bulletin is distributed on the 1st & 3rd Tuesday of the month for the CU Anschutz Research Community.